Horizon Therapeutics, an Irish biopharma company, has agreed to acquire Viela Bio, a US-based biotech company, for $53 per share in cash or about $3.05 billion in a move to significantly expand its development pipeline and grow its rare disease medicine portfolio. Viela Bio is focused on developing and commercializing therapies for a wide variety […]
Amgen said that sotorasib, an investigational KRASG12C inhibitor, has been given breakthrough therapy designation (BTD) from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China. The Chinese breakthrough therapy designation for sotorasib is for the treatment of patients having KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer […]
Nordic Capital has made an offer to acquire Advanz Pharma, a UK-based specialty pharma company, for about $846 million in cash. Advanz Pharma is said to focus strategically on complex medicines in Europe. The company’s expertise is in the anti-infectives and endocrinology therapy areas. As per the terms of the proposed deal, Advanz Pharma’s shareholders […]
The US Food and Drug Administration (FDA) has approved the combination of Bristol Myers Squibb’ Opdivo (nivolumab) and Exelixis’ Cabometyx (cabozantinib) as a first line therapy for advanced renal cell carcinoma (RCC), a type of kidney cancer. As per the FDA approval, Opdivo 240mg has to be injected intravenously every two weeks or 480mg every […]
Cabenuva FDA approval : ViiV Healthcare has secured approval from the US Food and Drug Administration (FDA) for its long-acting regimen Cabenuva for the treatment of HIV-1 infection in adult patients. According to ViiV Healthcare, Cabenuva is being given as a co-pack with a couple of injectable medicines that include the company’s integrase strand transfer […]
Eli Lilly and Company (Lilly) has completed its previously announced deal worth up to $1.04 billion of US gene therapy company Prevail Therapeutics. The US pharma giant said that the deal gives it a new modality for drug discovery and development. Furthermore, it will extend its research efforts via the creation of a gene therapy […]
BirchBioMed has reported positive results from a phase 2 trial evaluating the use of topical FS2, the company’s antifibrotic platform therapy, in the treatment of keloid scars. The Canadian clinical-stage immunology company said that the double-blind study delivered statistically significant results compared to Mederma, a market leading scar cream and a vehicle (placebo cream) in […]
The Russian Direct Investment Fund (RDIF) said that the Russian Sputnik V Covid-19 vaccine has been authorized for use by the UAE Ministry of Health and Prevention (MOHAP) in the country for providing protection against the SARS-CoV-2 virus. According to the Russian sovereign wealth fund, the Sputnik V vaccine was registered under the emergency use […]
Thermo Fisher Scientific has agreed to acquire California-based point-of-care molecular diagnostic company Mesa Biotech in a deal worth up to $500 million. The consideration includes nearly $450 million in cash and an additional amount of up to $100 million, which will be subject to Mesa Biotech achieving certain milestones post-acquisition. The molecular diagnostic company has […]
US medical diagnostic firm PerkinElmer has agreed to acquire Oxford Immunotec Global, a UK-based diagnostics company, for $22 per share or around $591 million. Oxford Immunotec is engaged in developing test kits for latent tuberculosis. The company’s Interferon Gamma Release Assay (IGRA) offering is used for detecting tuberculosis. As of 30 September 2020, Oxford Immunotec […]